X
GO
Overview

The HHS-wide initiative Ending the HIV Epidemic: A Plan for America seeks to leverage the powerful data and tools now available to reduce new HIV infections in the United States by 75 percent in five years and by 90 percent by 2030. HITEQ is identifying best practices and barriers to using health IT to support early diagnosis, application of proven prevention interventions including access to PrEP, and sustained treatment for people living with HIV to achieve and maintain viral suppression.

Search HITEQ Content
HIV Epidemic Resources
Event date: 5/27/2020 2:00 PM - 3:00 PM Export event
HIV Pre-Exposure Prophylaxis (PrEP) for Patients with Substance Use Disorders
Alyssa Carlisle

HIV Pre-Exposure Prophylaxis (PrEP) for Patients with Substance Use Disorders

Hosted by the HRSA-funded National Clinician Consultation Center

PrEP is a highly effective biomedical intervention that prevents HIV. Despite the established association between HIV risk and substance use, PrEP access as well as uptake and persistence among persons with substance use disorders remains low. To fully realize HIV prevention efforts across health systems, and as substance use/healthcare-seeking patterns evolve with COVID-19, person-centered PrEP service delivery needs to involve renewed and coordinated efforts involving substance use treatment providers. This webinar helped clinicians overcome PrEP implementation challenges, assess PrEP eligibility, and identify strategies for addressing side effect and adherence concerns. This webinar helped clinicians overcome PrEP implementation challenges, assess PrEP eligibility, and identify strategies for addressing side effect and adherence concerns.

Participants:
1. Examined national trends of PrEP use among different populations at risk for HIV, including persons with substance use disorders
2. Reviewed recent updates on new PrEP medications and dosing strategies, and discussed unique considerations that may arise when counseling persons with substance use disorders
3. Considered strategies for health centers to increase PrEP education, initiation, and persistence

Speaker information:
Parya Saberi, PharmD, MAS, AAHIVP, is an Associate Professor of Medicine at the UCSF Center for AIDS Prevention Studies and HIV Clinical Pharmacist. Funded by the National Institutes of Health (NIH) and California HIV/AIDS Research Program, her current areas of research include remotely-conducted research, adapting technology-based strategies to challenge current models of healthcare, and improving HIV prevention and treatment strategies through social networking technologies and web-based tools. She is Principal Investigator of an NIH-funded project to improve HIV PrEP prescribing practices through technology-guided panel management strategies in primary care clinics across the San Francisco Department of Health.

Previous Article HITEQ Highlights: Hear from your Peers: Using the EHR for Routine HIV Screening
Next Article Health Information Technology support for HIV Screening and Prevention Services
Print
1370

Acknowledgements

This resource collection was compiled by the HITEQ Center staff with guidance from HITEQ Advisory Committee members and collaborators of the HITEQ Center.